Veeva Systems Inc. (NYSE:VEEV) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• Analyst sentiment is positive: Twenty-eight brokerages give Veeva Systems a consensus “Moderate Buy” rating, including 19 buys, 8 holds and 1 sell. The average 12-month price target is approximately $284.46.
• Recent results exceeded expectations: Quarterly revenue rose 17.6% year over year to about $928 million, while adjusted EPS of $2.35 topped the $2.23 consensus estimate. Growth is being supported by Vault CRM migrations and expanding AI adoption.
• Valuation and insider activity warrant caution: Shares trade at roughly 45 times earnings after a substantial rally, while an insider sold 10,000 shares for about $2.8 million under a pre-arranged trading plan.

Veeva Systems Inc. (NYSE:VEEV - Get Free Report) has been given an average recommendation of "Moderate Buy" by the twenty-eight brokerages that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and nineteen have given a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $284.4583.

A number of research firms have weighed in on VEEV. Raymond James Financial reiterated an "outperform" rating and issued a $225.00 target price on shares of Veeva Systems in a research note on Thursday, June 4th. Wells Fargo & Company raised their price target on shares of Veeva Systems from $317.00 to $320.00 and gave the stock an "overweight" rating in a research note on Thursday, June 4th. Oppenheimer lifted their price target on shares of Veeva Systems from $225.00 to $300.00 and gave the stock an "outperform" rating in a report on Monday, August 17th. Piper Sandler upped their price objective on Veeva Systems from $295.00 to $320.00 and gave the company an "overweight" rating in a research note on Thursday, August 27th. Finally, BNP Paribas Exane reissued an "outperform" rating and set a $285.00 price objective on shares of Veeva Systems in a report on Thursday, June 4th.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Higher outlook and strong operating momentum: Veeva raised its fiscal 2027 outlook as Vault CRM migrations, research-and-development investment and Falcon AI adoption support revenue growth and expanding profitability. This follows a strong latest quarter, in which revenue increased 17.6% year over year to approximately $928 million and adjusted earnings exceeded analyst expectations. VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
• Positive Sentiment: AI adoption is broadening: Regeneron and Biogen have adopted Veeva’s AI-powered Vault CRM suite globally. Veeva also introduced Falcon Safety, an agentic AI product designed for biopharmaceutical safety operations. These developments could deepen customer relationships and expand Veeva’s role in commercial and safety workflows. Why Is Veeva Systems Winning Big in AI For Biopharma?
• Positive Sentiment: Long-term investor support: Commentary highlights Veeva’s recurring-revenue model, Vault CRM migration opportunity and AI expansion as reasons the stock remains attractive for long-term growth investors. Investor Michael Burry has also reportedly remained bullish on Veeva while criticizing Snowflake’s valuation. Burry Remains Bullish on Veeva
• Neutral Sentiment: Valuation and competition remain important considerations: Analysts and portfolio commentary generally support holding VEEV, but warn that market saturation could limit future growth. With the stock trading at a premium earnings multiple after a substantial rally, investors may require continued execution and strong guidance upgrades. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Negative Sentiment: Insider selling may weigh modestly on sentiment: Veeva’s exiting president sold 10,000 shares for approximately $2.8 million, representing about 51% of the executive’s direct equity stake before the transaction. The sale does not establish a change in business fundamentals, but it can raise caution after the stock’s strong advance. Veeva’s Exiting President Sold $2.8 Million in Stock

Insider Activity

In other news, insider Thomas Schwenger sold 10,000 shares of the company's stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the transaction, the insider owned 19,449 shares of the company's stock, valued at $5,471,587.17. This represents a 33.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Veeva Systems

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Williams Jones Wealth Management LLC. increased its stake in shares of Veeva Systems by 0.4% in the third quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company's stock worth $2,806,000 after purchasing an additional 40 shares in the last quarter. Rafferty Asset Management LLC lifted its stake in shares of Veeva Systems by 0.7% during the 2nd quarter. Rafferty Asset Management LLC now owns 6,881 shares of the technology company's stock valued at $1,982,000 after buying an additional 51 shares in the last quarter. Brown Brothers Harriman & Co. lifted its stake in shares of Veeva Systems by 8.1% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 719 shares of the technology company's stock valued at $214,000 after buying an additional 54 shares in the last quarter. Main Management ETF Advisors LLC boosted its holdings in Veeva Systems by 1.0% in the 4th quarter. Main Management ETF Advisors LLC now owns 5,481 shares of the technology company's stock worth $1,224,000 after buying an additional 56 shares during the period. Finally, Root Financial Partners LLC boosted its holdings in Veeva Systems by 17.1% in the 4th quarter. Root Financial Partners LLC now owns 383 shares of the technology company's stock worth $85,000 after buying an additional 56 shares during the period. 88.20% of the stock is currently owned by institutional investors.

Veeva Systems Trading Down 3.6%

VEEV stock opened at $274.02 on Friday. The stock has a market cap of $44.51 billion, a P/E ratio of 45.07, a P/E/G ratio of 1.21 and a beta of 0.97. The stock's fifty day simple moving average is $220.49 and its two-hundred day simple moving average is $187.95. Veeva Systems has a 1-year low of $148.05 and a 1-year high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last released its earnings results on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $2.23 by $0.12. The company had revenue of $927.96 million for the quarter, compared to analysts' expectations of $905.38 million. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%.The business's revenue for the quarter was up 17.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, analysts forecast that Veeva Systems will post 6.7 earnings per share for the current fiscal year.

About Veeva Systems

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source